A New Drug to Manage Resistant Chronic Pain

A new drug developed by Tel Aviv University researchers, BL-7050, is offering new hope to patients with neuropathic pain. In both in-vitro and in-vivo experiments measuring electrical activity of neurons, the compound has been shown to prevent the hyperexcitability of neurons – protecting against neuropathic pain.  READ MORE

Source: Science Daily

Join us in improving the lives of peripheral neuropathy patients.
Send this to a friend